Details for 2017175885
Up to date per 21.04.2026
Actions
Details for 2017175885
Granted/Registered
European Patent
20.02.2019 A
13.01.2021 B1
27.04.2012
US
201261687669 P
08.03.2013
US
201361775288 P
13.03.2013
US
201361780444 P
C07J 63/00 20060101AFI20191009BHEP
Owner
Reata Pharmaceuticals Holdings, LLC5320 Legacy Drive Plano, Texas 75024US
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
ANDERSON, Eric602 Nicholas Ct. Southlake, TX 76092US
DECKER, AndreaSpalenring 11 4055 BaselCH
LIU, Xiaofeng320 Meadowood Ln. Coppell, TX 75019US
Information about Fees